---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-011661"
form_type: "8-K"
ticker: "HRGN"
cik: "0001563665"
company_name: "Harvard Apparatus Regenerative Technology, Inc."
filed_at: "2022-08-02T23:59:59+00:00"
generated_at: "2026-06-24T05:54:10.384190+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Biostage shareholders approve reverse stock split ratio of 1-for-1.25 to 1-for-5

## Summary
- Proposal to amend charter to effect reverse stock split approved with 7,072,052 votes for, 196,116 against, 742 abstained.
- Board retains discretion to choose final ratio between 1:1.25 and 1:5 and to set timing within one year.
- Special meeting held July 28, 2022; result filed August 2, 2022.

## SEC filing metadata
- accession: 0001558370-22-011661
- form_type: 8-K
- ticker: HRGN
- cik: 0001563665
- company_name: Harvard Apparatus Regenerative Technology, Inc.
- filed_at: 2022-08-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563665/000155837022011661/0001558370-22-011661-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563665/000155837022011661/tmb-20220728x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-011661
- JSON: https://secwatch.observer/filing/0001558370-22-011661.json
- Plain text: https://secwatch.observer/filing/0001558370-22-011661.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.